Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.

Athanasios ArmakolasNektarios AlevizopoulosMartha StathakiConstantina PetrakiGeorge AgrogiannisMartina SamiotakiGeorge PanayotouEirini ChatzinikitaMichael Koutsilieris

Published in: British journal of cancer (2024)

These data indicate that the therapeutic targeting of PEc with the anti-PEc MAb may have considerable clinical benefit for prostate cancer patients.

Keyphrases

monoclonal antibody
prostate cancer
radical prostatectomy
electronic health record
cancer therapy
big data
machine learning
benign prostatic hyperplasia